Normal view MARC view ISBD view

Why employers will continue to provide health insurance: the impact of the Affordable Care Act. [electronic resource]

By:

Blumberg, Linda J

Contributor(s):

Producer: 20120919Description: 116-26 p. digitalISSN:

0046-9580

Subject(s):

Online resources:

Available from publisher's website

In: Inquiry : a journal of medical care organization, provision and financing vol. 49

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8
9
10

1 Unroofed coronary sinus defect.
by Kwok, O H
2 Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.
by Tse, Hung-Fat
3 Magnetic resonance whole body imaging at 3 Tesla: feasibility and findings in a cohort of asymptomatic medical doctors.
by Lo, Gladys G
4 Diagnosis of brainstem involvement in NK/T cell lymphoma.
by So, Jason C C
5 Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes.
by Tse, Hung-Fat
6 Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
by Lo, Gladys G
7 Virtual colonoscopy for the detection of colorectal polyps and cancers in a Chinese population.
by Wong, Benjamin Chun-Yu
8 Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis.
by Tse, Hung-Fat
9 Comparative evaluation of long-term clinical efficacy with catheter-based percutaneous intramyocardial autologous bone marrow cell implantation versus laser myocardial revascularization in patients with severe coronary artery disease.
by Tse, Hung-Fat
10 Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).
by Tse, Hung-Fat

Close